Literature DB >> 15863742

Pathogenesis of schizophrenia: a psychopathological perspective.

D G Cunningham Owens1, Patrick Miller, Stephen M Lawrie, Eve C Johnstone.   

Abstract

BACKGROUND: Despite interest in early treatment of schizophrenia, premorbid and prodromal symptomatology remain poorly delineated. AIMS: To compare pre-illness symptomatology in patients at high risk of schizophrenia who progress to illness with that of high-risk subjects who remain well and with normal controls.
METHOD: Using Present State Examination (PSE) data, symptomatic scales were devised from participants of the Northwick Park Study of first-episode schizophrenia and scores were compared on the first and last PSEs of participants of the Edinburgh High Risk Study.
RESULTS: At entry, when still well, high-risk individuals who subsequently became ill (mean time to diagnosis 929 days; s.e.=138 days) scored significantly higher on'situational anxiety', 'nervous tension', 'depression', 'changed perception'and 'hallucinations'than those remaining well and normal controls, who did not differ. With illness onset, affective symptomatology remained high but essentially stable.
CONCLUSIONS: In genetically predisposed individuals, affective and perceptual disorders are prominent before any behavioural or subjective change that usually characterises the shift to schizophrenic prodrome or active illness.

Entities:  

Mesh:

Year:  2005        PMID: 15863742     DOI: 10.1192/bjp.186.5.386

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  24 in total

1.  3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  Ruth Condray; George G Dougherty; Matcheri S Keshavan; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk; Jeffrey K Yao
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 5.176

2.  Prevalence and correlates of psychotic symptoms among Asian males.

Authors:  Mythily Subramaniam; Swapna Verma; Christopher Cheok; I-Min Lee; John Wong; Siow Ann Chong
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

3.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

Review 4.  Stress during critical periods of development and risk for schizophrenia.

Authors:  Felipe V Gomes; Xiyu Zhu; Anthony A Grace
Journal:  Schizophr Res       Date:  2019-01-30       Impact factor: 4.939

Review 5.  Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Authors:  Henk Temmingh; Dan J Stein
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

Review 6.  Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Authors:  Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

7.  Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis.

Authors:  Marina Myles-Worsley; Starla Weaver; Francisca Blailes
Journal:  Early Interv Psychiatry       Date:  2007-08-15       Impact factor: 2.732

8.  The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.

Authors:  Ahmed A Othman; George Haig; Hana Florian; Charles Locke; Lev Gertsik; Sandeep Dutta
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

9.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

10.  School-associated problem behavior in childhood and adolescence and development of adult schizotypal symptoms: a follow-up of a clinical cohort.

Authors:  Selene Fagel; Leo de Sonneville; Herman van Engeland; Hanna Swaab
Journal:  J Abnorm Child Psychol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.